Register
Login:
Share:
Email Facebook Twitter


Tech company Mporium delivers an outstanding set of Q1 results says CEO De Groot
IronRidge Resources CEO hails spectacular lithium project and money making potential for gold




Share Price Information for Faron Pharma (FARN)


Share Price: 61.00Bid: 60.00Ask: 62.00Change: 0.00 (0.00%)No Movement on Faron Pharma
Spread: 2.00Spread as %: 3.33%Open: 61.50High: 0.00Low: 0.00Yesterday’s Close: 61.00

Faron Pharmaceuticals Oy Ord Npv (Di)

Faron Pharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
61.00
Share Price SpacerBid
60.00
Share Price SpacerAsk
62.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
61.50
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
61.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 35.48m £21.64m 5,000

52 Week High 865.00 52 Week High Date 25-APR-2018
52 Week Low 51.00 52 Week Low Date 3-JAN-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -0.903 -67.53 0.00 0.00


London South East Users info for Faron Pharma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Apr-19
16:24:33
60.00
5,000
Sell* 
60.00
62.00
3,000
Trade Type:
Ordinary

18-Apr-19
15:31:58
61.58
2,947
Buy* 
60.00
62.00
1,815
Trade Type:
Ordinary

18-Apr-19
14:59:38
60.00
4,000
Sell* 
60.00
62.00
2,400
Trade Type:
Ordinary




View more Faron Pharma trades >>

Directors Deals for Faron Pharma (FARN)
Trade DateActionNotifierPriceCurrencyAmountHolding
28-Mar-19Placing
Trade Notifier Information for Faron Pharmaceuticals Oy (DI)
Markku Jalkanen held the position of CEO at Faron Pharmaceuticals Oy (DI) at the time of this trade.
 Markku Jalkanen
0.7EUR284,9003194290
28-Mar-19Placing
Trade Notifier Information for Faron Pharmaceuticals Oy (DI)
Yrjö E K Wichmann held the position of CFO at Faron Pharmaceuticals Oy (DI) at the time of this trade.
 Yrjö E K Wichmann
0.7EUR49,857124497
28-Mar-19Placing
Trade Notifier Information for Faron Pharmaceuticals Oy (DI)
Frank Armstrong held the position of Non-Executive Chairman at Faron Pharmaceuticals Oy (DI) at the time of this trade.
 Frank Armstrong
0.7EUR33,33355729
View more Faron Pharma directors dealings >>


itsallamess
Posts: 3,281
Opinion:No Opinion
Price:61.00
RE: Groundhog Day
Thu 22:49
Widows i personally would like to thank you for all your contributions with the discussions on FARN.

I assume from the capital letters you are shouting you reponse!
Zengah
Posts: 1,790
Opinion:No Opinion
Price:61.00
Admin
Thu 18:07
I would like to thank you for removing any abusive posts this morning...no one wants to listen to that.

Kindest,

Zen.
Zengah
Posts: 1,790
Opinion:No Opinion
Price:61.00
RE: Groundhog Day
Thu 18:06
Let the market decide....I'm happy with little volume as we are awaiting news.

If it drops on low volume it rises just as quickly...
widows
Posts: 15
Opinion:No Opinion
Price:61.00
Groundhog Day
Thu 17:44
WHAT I KNOW IS IM FED UP OF THE SAME OLD SAME OLD BE IT FROM MANY OR ZEN AS OTHERS HAVE STATED ILL BE BACK IN JUNE
itsallamess
Posts: 3,281
Opinion:No Opinion
Price:61.00
RE: Zen
Thu 16:09
Drac good point. The BOD were confident to buy in at 8.50 a share.

Its good to remember why this was 8.50... cause the phase 1 and 2 trials were so good!
If you watch some of the interview from before the big fall, the optimism was great.. it was a done deal really, hence 8.50 a share

But they knew it worked, "not for a moment did i believe the results" that was our CEO who just bought 200 grands worth!

Tell you alot about where this company is heading.
View more share chat for Faron Pharma (FARN) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.